- Report
- August 2024
- 322 Pages
Italy
From €1655EUR$1,850USD£1,433GBP
- Report
- August 2024
- 322 Pages
Germany
From €1655EUR$1,850USD£1,433GBP
- Report
- August 2024
- 322 Pages
France
From €1655EUR$1,850USD£1,433GBP
- Report
- August 2024
- 389 Pages
Global
From €6709EUR$7,500USD£5,808GBP
- Report
- January 2025
- 132 Pages
Global
From €850EUR$950USD£736GBP
The Enteric Disease market is a subset of the Infectious Disease Testing market, focusing on the diagnosis and treatment of diseases caused by bacteria, viruses, and parasites that affect the gastrointestinal tract. Enteric diseases can be caused by a variety of pathogens, including Salmonella, Shigella, Campylobacter, and Escherichia coli. Diagnostic tests for enteric diseases include stool culture, antigen detection, and molecular testing. Treatment options include antibiotics, antidiarrheal medications, and probiotics.
Enteric Disease testing is an important part of public health, as it helps to identify and contain outbreaks of foodborne illnesses. It is also used to monitor the effectiveness of food safety measures, such as food handling and sanitation practices.
Companies in the Enteric Disease market include Bio-Rad Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more